Argen X Se Adr (ARGX)

Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth By Investing.com - Investing.com South Africa

Dec 16, 2024

Dec 16, 2024

Argenx stock soars to all-time high of $630.4 amid robust growth - Investing.com

Dec 16, 2024

Dec 15, 2024

argenx's SWOT analysis: biotech stock soars on VYVGART success - Investing.com

Dec 15, 2024

Dec 12, 2024

Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance

Dec 12, 2024

Dec 11, 2024

Idiopathic Inflammatory Myositis Industry Assessment, 2020-2034: Breakthrough Therapies (Dazukibart and Efgartigimod) Propel Market Expansion Across the 7MM - GlobeNewswire Inc.

Dec 11, 2024

Dec 09, 2024

Argenx Expands Autoimmune Portfolio With Additional Vyvgart Approvals as Pipeline Develops - Morningstar

Dec 09, 2024

Dec 09, 2024

Piper Sandler maintains stock target on argenx, cites growth potential - Investing.com

Dec 09, 2024

Dec 02, 2024

Argenx stock soars to all-time high of $620.29 - Investing.com

Dec 02, 2024

Nov 30, 2024

10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey

Nov 30, 2024

Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth By Investing.com - Investing.com South Africa

Nov 26, 2024

Nov 26, 2024

Argenx stock soars to all-time high of $612.64 amid robust growth - Investing.com India

Nov 26, 2024

Nov 25, 2024

argenx's SWOT analysis: biotech firm's stock soars on VYVGART success - Investing.com

Nov 25, 2024

Nov 25, 2024

Jefferies reaffirms Buy rating on argenx stock, ups target amid promising trial updates - Investing.com India

Nov 25, 2024

Nov 21, 2024

Can Argenx stock sustain its autoimmune category dominance? Oppenheimer weighs in - Investing.com

Nov 21, 2024

Nov 21, 2024

Barclays bullish on argenx stock after positive trial results - Investing.com

Nov 21, 2024

Nov 21, 2024

Barclays bullish on argenx stock after positive trial results By Investing.com - Investing.com South Africa

Nov 21, 2024

Nov 20, 2024

argenx shares see price target boosted by Raymond James, Strong Buy rating upheld - Investing.com

Nov 20, 2024

Nov 18, 2024

10 Biggest Biotechnology Companies - Investopedia

Nov 18, 2024

Nov 12, 2024

Argenx upgraded at Wolfe on myasthenia gravis dominance - MSN

Nov 12, 2024

Nov 12, 2024

argenx stock boosted by Wolfe, citing dominance in MG and profitability ahead - Investing.com

Nov 12, 2024

Nov 11, 2024

Zai Lab and argenx Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in China - Yahoo Finance

Nov 11, 2024

Nov 05, 2024

Scotiabank raises argenx stock PT to $715, highlights efgartigimod's potential - Investing.com India

Nov 05, 2024

Nov 05, 2024

argenx SE's SWOT analysis: biotech stock poised for growth amid challenges - Investing.com

Nov 05, 2024

Nov 04, 2024

Deutsche Bank raises argenx target by EUR25, acknowledges momentum despite valuation - Investing.com

Nov 04, 2024

Nov 01, 2024

Argenx shares target raised by H.C. Wainwright, citing strong sales performance - Investing.com

Nov 01, 2024

Nov 01, 2024

Argenx Q3 Revenue, EPS Beats Excite Bullish Biotech Analysts: 'Most Enviable I&I Pipeline In Entire Industry' - Benzinga

Nov 01, 2024

Nov 01, 2024

Argenx shares target lifted, overweight on Vyvgart sales beat - Investing.com

Nov 01, 2024

Nov 01, 2024

argenx stock downgraded after 65% rally, Baird cites limited short-term upside - Investing.com India

Nov 01, 2024

Nov 01, 2024

William Blair bullish on argenx stock as Vyvgart flexes in CIDP and eyes new horizons - Investing.com India

Nov 01, 2024

Nov 01, 2024

Raymond James maintains outperform on argenx, cites strong sales - Investing.com India

Nov 01, 2024

Nov 01, 2024

argenx stock climbs as Truist highlights industry-leading I&I pipeline growth - Investing.com India

Nov 01, 2024

Nov 01, 2024

Stifel sees upside in argenx stock with robust pipeline and solid 3Q results - Investing.com

Nov 01, 2024

Oct 31, 2024

Earnings call: argenx sees growth with VYVGART, sets sights on CIDP - Investing.com Nigeria

Oct 31, 2024

Oct 31, 2024

Earnings call: argenx sees growth with VYVGART, sets sights on CIDP By Investing.com - Investing.com South Africa

Oct 31, 2024

Oct 31, 2024

Argenx stock soars to all-time high of $589.6 amid robust growth - Investing.com

Oct 31, 2024

Oct 31, 2024

argenx ADR earnings beat by $1.24, revenue topped estimates - Investing.com

Oct 31, 2024

Oct 30, 2024

argenx Reports Third Quarter 2024 Financial Results and Provides Business Update - Yahoo Finance

Oct 30, 2024

Oct 24, 2024

argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024 - The Bakersfield Californian

Oct 24, 2024

Oct 23, 2024

argenx SE's SWOT analysis: biotech firm's stock poised for growth amid challenges - Investing.com

Oct 23, 2024

Oct 21, 2024

Weekly Upgrades and Downgrades - InvestorPlace

Oct 21, 2024

Oct 18, 2024

Argenx stock soars to all-time high of $555.55 amid robust growth - Investing.com

Oct 18, 2024